Investigating genetic factors in hemophilia patients of Mexican descent

Omic Approaches to Factor VIII Inhibitor Development in Hemophilia Patients of Mexican Descent

NIH-funded research University of Texas Rio Grande Valley · NIH-10891149

This study is looking into why some people with severe hemophilia A, especially those of Mexican descent, develop antibodies that make their treatment less effective, and it aims to gather information and samples from these patients to help find better ways to treat them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Rio Grande Valley NIH-funded
Lab location1 site (Edinburg, United States)
Project IDNIH-10891149 on NIH RePORTER

What this research studies

This research focuses on understanding why a significant number of severe hemophilia A patients, particularly those of Mexican ancestry, develop antibodies that neutralize treatment. By enrolling and characterizing a cohort of severe hemophilia patients, the study will collect clinical data and blood samples to assess the risk of developing these inhibitors. Advanced techniques, including whole genome sequencing and mRNA sequencing, will be employed to analyze genetic and environmental factors contributing to this issue. The goal is to improve treatment outcomes for affected patients by identifying the underlying causes of inhibitor development.

Who could benefit from this research

Good fit: Ideal candidates for this research are severe hemophilia A patients of Mexican descent, particularly those who may be at risk of developing FVIII inhibitors.

Not a fit: Patients with hemophilia A who are not of Mexican descent may not benefit directly from the findings of this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for hemophilia A patients, reducing the incidence of inhibitor development and improving patient quality of life.

How similar studies have performed: Previous research has shown success in identifying genetic factors related to hemophilia, but this specific approach focusing on Mexican ancestry is relatively novel.

Where this research is happening

Edinburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Blood Coagulation Disorders
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.